A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agentsSylvia Herter(Roche (Switzerland)), Marina Bacac(University of Lausanne)Cancer Immunology ImmunotherapyNovember 17, 201610.1007/s00262-016-1927-1Cited by 137SaveCiteExport RISWatch citationsRelated PapersSecurin and Separase Modulate Membrane Traffic by Affecting Endosomal Acidification|Traffic|2011|28